Quantinuum Inc. QNT
Set alert
30.95 USD -2.65 -7.89%
At close · Nov 2
31.55 +0.60 +1.94%
After hours · Nov 2, 6:50 PM ET
30.89 Day range 33.94
30.95 52-week range 83.17
- YTD
- -48.74%
- 1 year
- -48.74%
- Open
- 33.94
- Prev close
- 33.60
- Mkt cap
- 8.22B
- Vol
- 2.04M
- Avg vol
- 1.89M
- EPS
- -1.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 30.89
- High
- 33.94
- Forward P/E
- -19.40
- Beta
- 0.00
- Short ratio
- 2.55
- Inst. own
- 97.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 45.53
- 200-d avg
- 54.28
- 1y target
- 95.83
MAX chart
Events in this range
- Aug 11, 2026Earnings: -0.28; estimate -0.25925; surprise -8%
- Aug 12, 2026Rating: Needham · Buy → Buy
- Aug 12, 2026Rating: Rosenblatt · Buy → Buy
- Aug 12, 2026Rating: Bernstein · Outperform → Outperform
- Aug 19, 2026Rating: Rosenblatt · Buy → Buy
- Oct 15, 2026Rating: Morgan Stanley · Equal-Weight → Overweight
- Oct 22, 2026Rating: Rosenblatt · Buy → Buy
- Nov 5, 2026Earnings: —; estimate -0.37446; surprise —%
Signals (21)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 2026 | 18 hours ago |
| SMA: Bearish | Oct 30, 2026 | 3 days ago |
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
Newest 20 of 21.
Financial health
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -28.1×
FY 2024 5y median -21.3× FY 2025
P/S 64.8×
FY 2024 5y median 78.0× FY 2025
P/B 1.2×
FY 2024 5y median 1.6× FY 2025
P/FCF -8.5×
FY 2024 5y median -12.0× FY 2025
EV/EBITDA -25.2×
FY 2024 5y median -78.8× FY 2025
EV/Sales 438×
FY 2024 5y median 541× FY 2025
FCF Yield -11.7%
FY 2024 5y median -9.1% FY 2025
Profitability
Gross Margin 62.2%
FY 2024 5y median 57.6% FY 2025
Operating Margin -1713.7%
FY 2024 5y median -1189.2% FY 2025
Net Margin -231.3%
FY 2024 5y median -429.1% FY 2025
ROE -4.2%
FY 2024 5y median -9.3% FY 2025
ROIC -29.6%
FY 2024 5y median -22.1% FY 2025
ROA -3.9%
FY 2024 5y median -8.7% FY 2025
Growth (YoY)
Revenue 34.6%
FY 2024 FY 2025
Operating Income -247.0%
FY 2024 FY 2025
EPS (diluted) 48.3%
FY 2024 FY 2025
Free Cash Flow -74.5%
FY 2024 FY 2025
Financial Health
Current Ratio 14.3×
FY 2024 5y median 10.4× FY 2025
Quick Ratio 14.3×
FY 2024 5y median 10.4× FY 2025
Debt / Equity 0.0×
FY 2024 5y median 0.0× FY 2025
Net Debt / EBITDA 1.4×
FY 2024 5y median 1.4× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31